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Bovine reproductive disease attributable to bovine herpes virus-1 (BoHV-1) was first described in Germany in the
19th century, being recognised primarily as the cause of infectious vulvovaginitis and balanoposthitis until the
mid-1950s when a more virulent strain of the virus (BoHV-1.1) associated with respiratory disease (infectious bovine
rhinotracheitis; IBR) emerged in the western United States. Subsequently, IBR emerged as a clinical condition in
Europe, from the 1970s onward. While the ability of BoHV-1 to produce respiratory disease is now well recognised,
the potential negative outcomes of infection on fertility and reproduction are less frequently considered. This
review was conducted against the background of the prioritization of disease caused by BoHV-1 as one of several
diseases to be addressed by Animal Health Ireland, with the twin goals of summarizing the published literature on
the potential outcomes of infection at different stages of breeding and pregnancy, and of describing the
emergence of BoHV-1 as a significant pathogen in Ireland and the UK.
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Addressing infection with bovine herpes virus-1 (BoHV-1)
in the Irish cattle population has been identified as a priority
for Animal Health Ireland (AHI; www.animalhealthireland.
ie), a not-for profit partnership between livestock farmers,
processors, service providers and government to address im-
portant non-regulated diseases that was established in 2009
[1,2]. More recently, Animal Health and Welfare NI
(AHWNI; www.animalhealthni.com) has been established in
Northern Ireland (part of the United Kingdom) with a simi-
lar remit, offering the possibility of dealing with BoHV-1
and other prioritized non-regulated diseases on an all-island
basis.
As will be described later in detail, the respiratory
form of BoHV-1 infection spread to Europe in the late
1960s and early 1970s and since then infectious bovine
rhinotracheitis (IBR) has been considered to be the pre-
dominant clinical disease associated with this virus,Correspondence: david@animalhealthireland.ie
Animal Health Ireland, Main Street, Carrick on Shannon, County
Leitrim, Ireland
© 2013 Graham; licensee BioMed Central Ltd.
Commons Attribution License (http://creativec
reproduction in any medium, provided the orincluding in Ireland. As a consequence, there has been
relatively little study or recognition of the reproductive
impact of BoHV-1 infection in recent years. In order to
better inform the debates being led by AHI and AHWNI
in the Republic of Ireland and Northern Ireland, this re-
view was conducted with two primary goals. Firstly,
drawing on published case reports, experimental trials
and epidemiological studies to highlight the negative
outcomes on reproductive performance that may be as-
sociated with BoHV-1. These may be divided into the
impacts on conception and the early stages of pregnancy
(fertility) and the ability of the virus to induce abortion
in mid to late gestation. The second goal was to review
the emergence of BoHV-1 in Ireland and the United
Kingdom (UK) as a cause of clinical disease and describe
the hypothesis put forward to explain this.Review
BoHV-1: historical perspective
The first report of disease believed to be due to bovine
herpesvirus-1 (BoHV-1) came from Germany in the 19thThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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or coital vesicular exanthema (CVE) was described. This
venereal disease was subsequently shown in 1928 to have a
viral aetiology when it was demonstrated that it could be
transmitted by a filterable agent [3]. Thereafter CVE, more
commonly referred to as infectious pustular vulvo-vaginitis
in cows and heifers (IPV) and infectious pustular
balanoposthitis in bulls (IPB) remained the primary
recognised manifestation of infection with BoHV-1
until the 1950s.
In 1954 a new clinical condition affecting dairy herds
in the Los Angeles area of California was described [4].
Following the index case in October 1953, 51 further
herds in the same area became affected over the next
4 months. Typical presenting signs included a high fever
(38.9–42.2°C) and a sudden drop in milk yield which in
many cases ceased completely within 24–48 hours. Exces-
sive salivation was commonly reported and the mucous
membranes of the nares were inflamed with a nasal dis-
charge which was initially mucus and later mucopurulent.
A short explosive cough was also characteristic of the dis-
ease. Morbidity in these herds was 7.6% with a mortality
rate among infected animals of 3%. Affected animals
returned to normal fairly rapidly with evidence of the
acute phase typically disappearing within one month. On
post-mortem examination the most prominent and char-
acteristic lesion was severe haemorrhagic tracheitis and
bronchitis. While diarrhoea was not a clinical sign, severe
enteritis of the small intestines and mucoid enteritis of the
large intestines were reported. The aetiology was believed
to be viral and this report is now considered to be the
first peer-reviewed description of infectious bovine
rhinotracheitis (IBR) in cattle.
The following year (1955), a report was published [5] de-
scribing an emerging respiratory disease of feedlot and dairy
cattle which it named infectious necrotic rhinotracheitis.
This report was the first to use the term “red nose” in rela-
tion to this disease, in reference to the marked inflammation
of the nasal pad and passages. This was first observed in the
autumn of 1950 in Colorado and consistent with the report
from the previous year [4], was characterised by a high fever
and acute inflammation affecting the upper respiratory tract
down to and including the bronchi. Following its emergence
in Colorado in 1950, signs were observed in a number of
feedlots between 1951 and 1953 with affected cattle to this
point typically being mature animals. This changed in 1954
when the disease was recognised in calves as young as
3 weeks of age and also occurred in epizootic form in dairy
herds. Clinical signs were again similar to those described in
the index case [4] with a sharp reduction in milk yield in-
cluding cessation in some animals with recovery in 5–7 days
and changes in the gastro-intestinal tract with mucosal ul-
ceration in the abomasum, severe enteritis in the small in-
testine and mild inflammation in the large intestine. Unlikethe index case diarrhoea was reported as a presenting sign
in some cases, with animals having fresh or digested blood
in their dung which in some instances was linked to aboma-
sal ulceration.
Based on the results of restriction endonuclease ana-
lysis, isolates of BoHV-1 can be subdivided into three
subtypes. BoHV-1 type 1 (BoHV-1.1) isolates are typic-
ally associated with respiratory disease and abortion and
are sometimes referred to as being IBR virus-like. A sec-
ond group of viruses, referred to as BoHV-1.2 are typic-
ally associated with venereal infection and are referred
to as being IPV-like. This grouping can be further
subdivided into BoHV-1.2a and −1.2b, being clinically
distinguished by the association of the former with abor-
tions, although these distinctions between subtypes are
not absolute [3,6-8].
Fertility
Experimental studies at service/oestrus
The potential for BoHV-1 infection to have a negative
impact on fertility has been recognised for many years.
One of the earliest reports, published in 1967 described
an experimental study to investigate the impact of the
presence of BoHV-1 in semen used in artificial insemin-
ation (AI), [9]. Initially, 4 heifers were inseminated with
semen spiked with the U.S. BoHV-1 strain K22 (BoHV-
1.2b, IPV-like; [10]), with the semen being deposited in
the body of the uterus. Each heifer showed clinical signs
of IPV, with 3 returning to oestrus 9–13 days later while
the fourth conceived and ultimately produced a live calf
at term. In a follow-up study 6 of 8 seronegative heifers
inseminated in the same way had short oestrus cycles
(11–15 days). Endometrial biopsies indicated the devel-
opment of a chronic necrotising endometritis which was
still evident 31–47 days after insemination. Histopatho-
logical changes were also observed in the vulva, vagina
and oviducts of some animals at this stage and 5 of 8 ani-
mals examined had cystic corpora lutea.
A subsequent more detailed study, [11] investigated
the effect of BoHV-1 on breeding by both AI and natural
service. Seronegative heifers and cows were either in-
seminated with semen and an Australian strain of
BoHV-1 or were mated naturally to bulls which had
been inoculated preputially 2 days previously with the
same virus. Following AI, when semen was deposited
into the uterus, only 2 of 10 animals conceived to first
service, with a further 2 animals conceiving to a second
BoHV-1-free insemination. In addition 4 of the 6 non-
pregnant animals showed one or more shortened oestrus
cycles. Overall there were 4.5 services per conception in
this group as compared to 1.7 services per conception in
a control group where 9 of 10 conceived within 2 insem-
inations with no incidences of shortened oestrus cycles.
In contrast, breeding by natural service produced similar
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bred by non-infected bulls were pregnant after 2 services
whereas 9 of 10 bred by BoHV-1-infected bulls were in
calf with respective services per conception of 1.2 and 1.4.
Irrespective of the means of service all animals receiv-
ing BoHV-1-infected semen developed lesions of IPV
within 48 hours which regressed 9–11 days later, with
the inoculated bulls developing IPB. In the artificially in-
seminated group, virus was recovered consistently from
vaginal swabs from all animals with a mean duration of
excretion of 8.8 days. Virus was intermittently recovered
from some animals for as long as 40 days post insemin-
ation. Histopathological examination of the 6 non-
pregnant animals in the AI group showed lesions of
chronic endometritis ranging in nature from mild to se-
vere. Lesions were also recorded in the oviduct, vagina
and Bartolin’s glands.
The authors concluded that the route of infection is
critical in determining whether endometritis and infertil-
ity occur. While the introduction of BoHV-1 by natural
service does not appear to significantly affect fertility,
the inoculation of BoHV-1 into the uterus can cause in-
fertility due to endometritis and also increase the inci-
dence of shortened oestrus cycles.
The potential negative impact of the use of BoHV-1
-contaminated semen was also highlighted by a field
study which who reported that cows in 20 herds insemi-
nated with contaminated semen had a non-return rate
of 13.4% compared with 60.8% when semen from other
bulls was used [12]. In addition 22.1% of cows returning
to service in the infertile group had shortened oestrus
cycles.
In the 1980’s an American research group highlighted
the lack of information concerning the effect of BoHV-1
on the reproductive organs of cattle that were non-
pregnant or in early gestation [13] and conducted a
number of studies to investigate this. In the first of these
[13], 12 seronegative heifers were inoculated by the
intrauterine route one day after natural mating with a
non-infected bull. 4 heifers received strain FI (Foetal
Iowa) (type BoHV-1.2a [8]) while the others received
one of two other strains–(Iowa or Colorado; type BoHV-
1.1 [8]). Animals were subject to post mortem examin-
ation 4–14 days later. The corpus luteum (CL) of 8 of
the 12 virus-inoculated heifers, representing all 3 inoc-
ula, contained cysts. No gross or microscopic lesions
were observed in the control heifers or those inoculated
with the FI isolate. In contrast, gross lesions of oedema,
haemorrhage and necrosis were recorded in the uterine
bodies or horns of the heifers that were inoculated with
either of the other strains. Microscopic lesions ranging
from mild focal endometritis to severe diffuse necrotiz-
ing metritis were also observed in these groups. In
addition to the luteal inflammation, 2 heifers had areasof necrosis in the contra-lateral ovary, with one having a
severe, diffuse, necrotizing oophoritis.
Based on these findings, the authors drew a number of
conclusions. Firstly, the absence of gross lesions in the
cranial uterine horns, accompanied by minimal micro-
scopic changes, were unlikely to interfere with blastocyst
attachment in this area 3 weeks after conception and
therefore the infertility associated with intra-uterine ex-
posure is unlikely to be a direct consequence of the patho-
logical effects of the virus on the uterine epithelium.
Secondly, BoHV-1 can produce inflammation and ne-
crosis of the CL after intra-uterine exposure at oestrus.
However, they concluded that the intra-luteal cysts are
probably not a direct result of viral damage due to the
lack of correlation between their presence and the detec-
tion of lesions or the isolation of virus (which was not
isolated from all corpora lutea) in challenged cattle and
their occurrence in some control animals also.
The difference in outcomes between BoHV-1 isolates
is noteworthy. In a follow up study [14] the Colorado
and Iowa isolates were used to infect seronegative
heifers on the day after breeding by natural service. For
each virus isolate, 2 heifers were each inoculated by the
intravenous (i.v.), intramuscular (i.m.) and intra-nasal
(i.n.) routes, with animals being subject to post mortem
examination 11–15 days later. Gross ovarian lesions were
found in the ovaries of 4 heifers (3 i.v., 1 i.m.). Microscopic
ovarian lesions were found in all 4 animals inoculated by
the i.v. route and 3 of 4 by the i.m. route, with virus being
recovered from the ovaries of each of these animals
but not from other parts of the reproductive tract. No
gross or microscopic lesions were detected in the ovar-
ies of animals exposed by aerosol route and virus was
not isolated from their ovarian tissue. The authors
concluded that BoHV-1 readily gains access to ovarian
tissue from the blood and that the immediate post-
oestrus ovary is particularly susceptible to infection via
this route. They proposed that the absence of ovarian
lesions following aerosol infection probably reflects the
absence of a viraemia with the incidence of ovarian in-
volvement related to the duration and height of post-
infection viraemia.
The Iowa and Colorado isolates were then used to
conduct a further study [15] to investigate the effect of
BoHV-1-induced oophoritis on ovarian function during
an acute primary i.v. infection and after recovery and re-
activation of latent infection. Six heifers were inoculated
by the i.v. route with either Iowa (n = 3) or Colorado
(n = 3) isolates at oestrus following natural service.
Plasma progesterone was followed over subsequent cy-
cles to monitor CL function and was found to be de-
pressed in all heifers. The reduction in progesterone
was more marked with the Iowa isolate. Two heifers
had a normal next oestrus cycle whereas for 3, onset
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remaining heifer returned to normal cyclicity after
2 months. The authors concluded that while primary
BoHV-1 infection at oestrus may cause severe oophor-
itis, the resulting functional impairment of the ovary is
temporary. None of the heifers became pregnant, although
the authors were unable to state whether this reproductive
failure was as a result of necrosis of the CL or lethal em-
bryonic infection. Despite the i.v. route of administration,
virus was isolated from the nasal (n = 5), vaginal (n = 6)
and rectal (n = 1) mucosal surfaces from the six heifers
after reactivation. No lesions were observed on the ovaries
of any heifer and virus was only isolated from the ovarian
tissue of one animal, suggesting that recurrent BoHV-1 in-
fection does not directly interfere with ovulation or luteal
function.
To compare the pathological changes induced in the
ovaries by different modified live IBR vaccines administered
during oestrus, 22 seronegative heifers were synchronised
with 2 doses of prostaglandin and then administered
double doses by the intravenous route of one of three
modified live vaccines licenced in North America [16].
BoHV-1 was isolated from blood and nasal and vaginal se-
cretions from each of the three vaccine groups. The heifers
were ovariectomized nine days after vaccination for histo-
logical investigation and virus isolation. In all three groups
necrotic oophoritis with multifocal areas of ovarian tissue
necrosis, haemorrhage and mononuclear lymphocytic infil-
tration was observed. While some differences were ob-
served between vaccine strains these were not statistically
significant. Similar outcomes have been shown in pigs vac-
cinated with a pseudorabies (Aujezsky’s disease) virus vac-
cine [17], suggesting that the ability to induce necrotic
oophoritis when administered at oestrus is a characteristic
of alphaherpesviruses. It should be noted that studies
(e.g. [16]) that describe pathological outcomes associ-
ated with IBR vaccine strains are included to illustrate
the potential pathogenicity of BoHV-1, rather than of
vaccine viruses as a generic group. Indeed the studies
cited were typically conducted using early vaccines licenced
for use outside Europe. The European Pharmacopoeia [18]
that lays down the criteria for licensing of live IBR vaccines
requires data from a minimum of 24 pregnant cows at
various stages of gestation and administered ten times the
vaccinal dose of virus to demonstrate the absence of either
abortion or antibodies to BoHV-1 in pre-colostral sera.
A later study also investigated the impact of vaccine-
induced changes on fertility [19], administering a modi-
fied live IBR vaccine i.m. to ten heifers that received two
doses of prostaglandin ten days apart. Vaccine was given
on the second of these treatment days at which time
each animal in the trial was placed with a proven sire for
35 days and resulting conception rates were monitored.
The conception rate in the control group of nineanimals was determined to be 78% to first service rising
to 100% following second service. In contrast only 30–
40% of the ten heifers in the vaccinated group conceived
to first service rising to 70% after second service. The
authors attribute the marked difference in conception
rates to a profound negative influence of concurrently
administered vaccine virus on fertility.
Experimental studies-early pregnancy
All of the previous studies focused on infection with
BoHV-1 at the time of oestrus. To evaluate the outcome
of infection at different developmental stages of the bo-
vine CL and conceptus, pairs of heifers were inoculated
i.v. with the Iowa strain 7, 14, 21 and 28 days post nat-
ural service with post mortem examination 13–15 days
after inoculation [20]. In contrast to the severe oophor-
itis reported in earlier studies associated with infection
at oestrus, heifers inoculated at 7 or 14 days post natural
service had mild oophoritis with a few necrotic follicles
in one or both ovaries. Those inoculated 21 or 28 days
post breeding had no lesions in the corpus luteum but
numerous necrotic follicles in their ovaries, with viral
antigen observed in all lesions by immunohistochemis-
try. The uterus of one heifer inoculated 7 days post-
breeding contained a degenerating conceptus from which
BoHV-1 was isolated. Heifers inoculated 14 days post-
breeding were found not to be pregnant, but there was
evidence that the post-breeding oestrus cycle had been
longer than normal suggesting that conception followed
by early embryonic death had occurred. The uteri of
heifers inoculated at 21 or 28 days post-breeding (and the
other heifer inoculated on day 7) contained normal-
appearing concepti. Thus the results indicate that the
pathogenic effect of BoHV-1 on the CL depends on the
stage of development, with the severity of lesions decreas-
ing as the interval from breeding to exposure increased.
Shortly after ovulation, intense neo-vascularization de-
velops in the follicular theca interna, and the authors
speculate that infection occurring at oestrus can result in
a large number of cells being simultaneously exposed to
virus and leading to diffuse necrosis of the CL. In contrast,
infection when the CL is fully functional and less
vascularized may result in a lower level of exposure and
subsequent pathology.
Having previously identified the diffuse necrosis of the
CL and subsequent progesterone deficiency that accom-
panies infection at oestrus as one means by which
BoHV-1 can prevent continued pregnancy, these authors
considered cytocidal infection of the developing concep-
tus occurring when heifers are inoculated 7–14 days
after breeding as a further mechanism by which infec-
tion may impact fertility. In this case embryonic death is
not the result of luteal damage but rather cytocidal in-
fection of the trophoblast.
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tility of heifers in the early embryonic period, the same
researchers exposed 2 groups of recently served, sero-
negative heifers to BoHV-1 by the i.v. route either 7 or
14 days post-breeding [21]. Pregnancy occurred in all 5
control non-inoculated heifers, whereas only 1 of 8 inoc-
ulated heifers maintained pregnancy. These results were
attributed to early embryonic death rather than a failure
to conceive with inter-oestrus periods typically normal
or only slightly longer than would be expected in the ab-
sence of conception. 3–4 months later all inoculated
heifers were treated with dexamethasone and tissues
subjected to histological and virological examination.
Virus was isolated from the adrenal glands of 7 out of 8
of the challenged heifers and from vaginal and nasal
swabs of 5 and 3 of these heifers respectively. Virus was
also isolated from the reproductive tissues of one
(ovary, infundibulum and uterine tube). Histological
changes were observed only in the adrenal glands be-
ing characterised by a lymphohistiocytic infiltration ac-
companied less frequently by necrotic foci.
In an earlier study, the same researchers had shown
that isolate FI had reduced pathogenicity compared to
Iowa and Colorado strains in terms of its ability to cause
endometritis and oophoritis when challenge occurred at
the time of oestrous [13]. To further characterise this
isolate they conducted a study to test its effect on preg-
nancy and determine whether it was pathogenic for the
developing corpus luteum in heifers [8]. Nine seronega-
tive heifers were bred naturally and inoculated i.v. with
isolate FI (BoHV-1.2a) with 2 each being inoculated at 1,
7 and 14 days post-breeding (DPB) and the remaining 3
at 6 months gestation. Plasma progesterone was moni-
tored to follow CL function with low values and failure
to conceive being recorded for the 2 heifers inoculated
at DPB 1. Luteal function was normal in heifers inocu-
lated on DPB 7 and 14 with these 4 heifers producing
healthy uninfected calves at term. These effects at DPB 7
and 14 differed from those observed with Iowa and
Colorado strains (both BoHV-1.1 [20]). The 3 heifers in-
oculated with FI at 6 months all produced a calf at term
although one was delivered dead. No virus was isolated
from this calf but it was cultured from the placenta. The
authors considered that BoHV-1 could be present in
cotyledonary tissue without inducing lesions or infecting
the foetus. The authors speculate that the FI isolate is
less prone to cause reproductive failure because it is an
IPV-type (BoHV-1.2) virus rather than an IBR (BoHV-
1.1) type, with the former being considered as non-
abortifacient. This was based on the observation that
abortion is typically not seen in association with venereal
disease (which is typically attributed to BoHV-1.2
strains) and that the recognition of the abortifacient ac-
tivity of BoHV-1 coincided with its emergence as a causeof IBR in North America (with the latter typically attrib-
uted to BoHV-1.1 strains).
Epidemiological studies
Several epidemiological studies have investigated the im-
pact of BoHV-1 on reproductive performance in dairy
and beef herds. One of these [22] examined the impact
of natural subclinical infections on fertility losses in a
limited number of non-vaccinated dairy cows and heifers
in Turkey. The study comprised 201 cows and 89 heifers
cattle in 107 different herds, all of which were insemi-
nated by a single individual using semen from the same
bull. The average days open for cows that were seroposi-
tive at the time of service (99.3 ±16 days) was signifi-
cantly higher than that recorded for seronegative cows
(82.0 ±3.8 days). Conception rates were higher in sero-
negative (38.98%) than in seropositive cows (33.33%).
Conversely, the conception rate was higher in seroposi-
tive (84.61%) than seronegative (56.57%) heifers, al-
though in neither case were the differences statistically
significant. The authors suggest that the better repro-
ductive performance of seropositive heifers could be a
consequence of their prior immunity to BoHV-1 at the
time of service, although it might be expected that a
similar protective effect would have been evident in the
cows.
In a larger study of Estonian dairy herds comprising
9,637 animals in 65 seropositive and 38 seronegative
herds, BoHV-1 was found to be significantly related to
reproductive performance with the highest risk of in-
creased insemination index and abortions occurring in
herds with a moderate seroprevalence [23]. The odds ra-
tios for these two events were 5.2 (95% C.I. 1.5–18.4)
and 7.3 (95% C.I. 2.0–26.9) respectively. This study did
not find a significant association between BoHV-1 and
acute respiratory disease in adult cattle, although a sep-
arate analysis of the data did find a high occurrence of
respiratory disease in unweaned calves to be associated
with both a low to moderate (OR 14.8) and a high (OR
19.2) seroprevalence of BoHV-1 among cows [24].
A recent study of eight commercial dairy herds in
Ireland [25] found a significant association between
serological evidence of exposure to BoHV-1 and reduced
conception rate.
In contrast a large study of Canadian beef herds [26]
found no evidence of association between BoHV-1 sero-
logical status and reproductive performance.
Abortion
The ability of the virus causing IBR to also induce abor-
tions has been known for many years [27]. In North
America the ability of both wild type field strains and early
modified live vaccines to induce abortion has been
recognised with one of the earliest reports from 1964 [28]
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a naturally occurring outbreak, experimental studies and
following use of modified live vaccine in pregnant cattle.
This study suggested an age-related susceptibility of the
foetus with almost all abortions occurring in cows preg-
nant for at least six months. In the natural outbreak de-
scribed in the same report there had been no obvious
intercurrent disease seen in the herd. Similar lesions were
found in all foetuses examined and distinctions could not
be made between abortions caused by natural infection,
experimental infection or vaccination. Characteristic
gross lesions were not observed in any foetuses but on
histological examination the typical lesion observed
was of focal necrosis and this was considered to have
considerable specificity for the disease. While focal ne-
crosis was found in many tissues, it was best observed
and occurred with greatest consistency in the liver. Le-
sions were also common in the spleen, thymic lobules,
lymph nodes, kidney, adrenal cortex uterine endomet-
rium and placenta.
A later epidemiological study [29] of 1,816 cows in 26
herds with abortion problems found a causal relation-
ship between use of an early modified live IBR vaccine
and abortion and infertility. The authors reported that
cows vaccinated as adults with modified live vaccine
prior to breeding had a 47.7% abortion rate, pregnant
cows in contact with vaccinated calves had a 20.5% abor-
tion rate and non-vaccinated exposed cows had an abor-
tion rate of 17.9%.
A separate report [30] also described an outbreak of
abortion in a dairy herd following i.m. administration of
a modified live IBR vaccine. Of the thirty pregnant vacci-
nated cattle, twenty three pregnancies of four to six months
duration were terminated by abortion or foetal death be-
tween 21 and 112 days after vaccination, representing a
total pregnancy loss of 76.7%. Seven pregnancies yielded a
mummified foetus.
In contrast, an early study [31] demonstrated the effi-
cacy of an i.m. IBR vaccine against abortion. Challenges
were conducted either i.n. or i.m. with one of two viru-
lent field strains of BoHV-1: P8 isolated from respiratory
disease in cattle and V11 isolated from an aborted
foetus. Following challenge by either route, classical re-
spiratory signs of IBR were seen in both control groups,
albeit that a shorter and milder clinical course was ob-
served following i.m. challenge, accompanied by a shorter
duration of viral shedding from the nose. A high incidence
of abortion occurred in control heifers with 10 of 16
heifers (62.5%) aborting compared to 1 of 17 (5.9%) of
vaccinated heifers. Key observations in this study were
that the incidence of abortion was not affected by factors
including route of challenge inoculation, the strain of virus
or the stage of pregnancy (3–6 months). Abortions in the
control groups occurred between 8 and 41 days postchallenge and the authors noted a greater success in iso-
lating virus from placenta as compared with foetal tissues.
This observation was supported by the findings of
other studies [32,33] which also highlighted placental tis-
sue as a suitable diagnostic specimen, with the latter
reporting the presence of culturable virus in the cotyle-
dons of the placenta of 13 of 13 pregnant cows inocu-
lated with BoHV-1 by the i.m. route. No virus-specific
lesions were observed in the cotyledons of any of the 13
foetuses.
Other studies [34] have also demonstrated the efficacy
of an intranasal IBR vaccine in preventing abortion.
However, while the vaccine itself was shown to be both
safe and efficacious in this study, the results from con-
trol groups challenged i.n. again demonstrated the abor-
tifacient properties of BoHV-1. In the first control group
foetuses averaged 8.5 months of age at challenge, ran-
ging from 7.5–9 months. Out of 8 foetuses, 3 were born
normally and remained healthy, 3 were born at term but
died by 12 days of age, 1 was born prematurely, dying
shortly after birth, and the final foetus was aborted. In
the second control group foetuses averaged 6.5 months,
(3.5–9 months) at the time of challenge. Only one off-
spring was considered normal with 2 being born alive
but dying within one week and the remaining 5 being
attributed to foetal wastage (abortions, mummification
or premature birth). Thus, overall, 12 of 16 controls
aborted, had a mummified foetus, foetus with latent
infection or calved prematurely, or gave birth to calves
that died by 12 days of age. The authors acknowledge
that calves that died after birth may have contracted
infection either in utero, by inhalation post-natally or
by both routes.
A more detailed study [35] of 4 of these 5 calves that died
shortly after birth reported lesions primarily characterised
by focal necrosis distributed in many different tissues. In
particular they highlighted the presence of these in the
reticulum, rumen, omasum, abomasum, small and large in-
testines. Areas of haemorrhage were also present, particu-
larly in the stomachs.
To further investigate the abortifacient properties of
different BoHV-1 strains [10] 3 heifers were inoculated
with the Cooper isolate (BoHV-1.1), 3 with the FI isolate
(BoHV-1.2a) and 5 with the K22 isolate (BoHV-1.2b). In-
oculation was carried out by the i.v. route 25–27 weeks
after breeding. All heifers given the Cooper and FI iso-
lates aborted 17–85 days after inoculation with foetal in-
fection confirmed in all cases by immunohistochemistry
and in some by virus isolation. All 5 heifers inoculated
with K22 delivered full term calves. Placenta was avail-
able from 4 of these with K22 isolated from each one in-
dicating that the virus had crossed the foetal–maternal
barrier. In addition 4 of the 5 calves had BoHV-1
neutralising antibodies in pre-colostral sera indicating
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able of killing them.
Overall the results suggested that BoHV-1.1 or 2a
isolates caused abortion whereas BoHV-1.2b strains
may infect the foetus but may be incapable of consist-
ently causing foetal death. The authors noted the
conflicting results in relation to the FI strain between
this and their earlier study [8] and highlighted the
need for repeated trials to characterise the aborti-
facient potential of individual strains. They also
highlighted the problems associated with the use of
BoHV-1 strains in respiratory vaccines available in the
USA at that time due to their abortifacient potential in
pregnant cattle.
However, while BoHV-1.1 strains are typically consid-
ered to be responsible for more severe clinical signs,
they may also be associated with subclinical infections,
including a report of a breakdown in a sero-negative 230
cow dairy herd in the United Kingdom [36]. Apart from
slight watery ocular discharge in less than 5% of cows,
no other clinical signs were observed.
A sub-clinical outbreak caused by BoHV-1.1 has also
been described in a Dutch dairy herd [37]. Again, no
clinical signs were observed in newly infected animals
but detailed analysis of milk recording data showed a
significant drop in milk production in animals that were
initially seronegative. This production loss was estimated
at approximately 9.5 litres per animal during the infec-
tious period of 14 days. No pregnant cows aborted and
overall there was no significant difference in the propor-
tion of successful inseminations between cattle that were
initially seropositive or seronegative.
In a study of 100 Estonian dairy herds [38], blood sam-
ples from 1,973 animals were tested, with herds being
divided into 3 groups based on BoHV-1 seroprevalence
(0, 1–49 and ≥50%). Herds in the 1–49% (OR 6.66,
1.82–24.35, 95% CI, p = 0.004) and ≥50% (OR 3.70,
1.00–13.71, 95% CI, p = 0.05) seroprevalence groups
were found to have a higher odds ratio of having in-
creased rates of abortion and herds in the highest
seroprevalence group to have a trend toward a higher
odds ratio for stillbirth (OR 3.38, 0.93–12.22, 95% CI,
p = 0.06).
History of IBR in the UK and Ireland
United Kingdom
IBR as a clinical entity was first described in the UK in
1961 [39] with the BoHV-1.2b (Oxford strain) isolated
from this outbreak being designated as the British-type
strain [6,7]. However it was not until the winter of 1977
that widespread reports of a sudden rise in the incidence
and severity of IBR outbreaks, typically associated with
high herd morbidity and variable but significant mortal-
ity, emerged in mainland UK.This is illustrated by a review of changing trends in
IBR in Great Britain [40] which analysed data from dif-
ferent sources covering the period from 1970–1986.
Despite inherent limitations in the data, a significant in-
crease in the incidence of IBR was evident in the late
1970s. This was associated with an increase in the preva-
lence of seropositive animals among healthy cattle, when
it rose from less than 5% in the early 1970s to 10–12%
in the mid 1980s, and in diseased cattle when it rose
from 9.1% to 34.8% during the same period. Corre-
sponding changes in herd seroprevalence occurred, in-
creasing from 17.6% to 48%. A marked seasonal trend in
respiratory disease attributed to IBR was apparent with a
peak in the winter months. During this same period
there was a significant rise in the number of BoHV-1
-related abortions, which had a year-round distribution
with a peak in July and August, consistent with au-
tumn calving patterns.
A subsequent study [6] described the predominant ge-
notypes of BoHV-1 in the UK. The majority of isolates
analysed were made in England and Wales made be-
tween 1977 and 1987, but also included five isolates
from Northern Ireland (N.I.) obtained between 1964 and
1984, the British type strain (Oxford) and four early
isolates from the 1960s. All four of these early isolates
were shown to be BoHV-1.2b strains. In contrast 66 of
73 isolates from Great Britain between 1977 and 1987
belonged to BoHV-1.1, with the remaining 7 belonging
to BoHV-1.2b. There was no particular association be-
tween strain type and clinical signs, with ocular signs
recorded for 5 of the 7 BoHV-1.2b isolates. All of the
N.I. isolates were BoHV1.2b, with these frequently be-
ing found in association with respiratory disease. The
authors hypothesised that a variant or mutant BoHV-1
emerged in the early 1950s in the USA and that on one
or more occasion subsequently this new virus type was
introduced to Europe through the importation of la-
tently infected cattle.
To further investigate the differences in clinical re-
sponse to different strains of BoHV-1, i.n. challenge
studies were conducted in seronegative calves using
BoHV-1.1 and BoHV-1.2b strains [7]. All calves devel-
oped clinically apparent disease post-challenge which
was qualitatively similar for all six viral strains. However
it was shown that quantitatively, clinical scores due to
BoHV-1.1 strains were significantly higher overall than
those due to BoHV-1.2b strains. Associated with this
there was significant variation in cumulative virus shed-
ding, being higher in BoHV-1.1 strains which also had
significantly higher virus titres in nasal mucus. The au-
thors consider this supporting evidence for the hypoth-
esis that up to and including the 1960s, BoHV-1.2b
strains were endemic in British cattle at low prevalence
causing sporadic outbreaks of genital and relatively mild
Graham Irish Veterinary Journal 2013, 66:15 Page 8 of 11
http://www.irishvetjournal.org/content/66/1/15respiratory disease. From the mid 1970s onwards a more
severe form of IBR associated with BoHV-1.1 emerged
with a greater tendency to spread, reflecting higher titres
of virus in nasal mucus and probably introduced with
imported cattle from North America.
These findings are consistent with a much earlier
publication [41] which reported a comparative i.n.
study in calves with 3 European isolates of BoHV-1
from cases of IPV from Germany, Belgium and Austria
and an isolate from a case of IBR in a Californian dairy
herd. Calves inoculated with the Californian BoHV-1
isolate produced typical signs of IBR. Respiratory signs,
although less marked, were also evident with the European
isolates, with the milder response being attributed to a
decreased affinity of the viruses for the respiratory tract
tissues.
Consistent with the change in predominant strains of
BoHV-1 in the UK, outbreaks of IPV are now rarely
reported but do continue to happen. In one such case
[42] an outbreak caused by a BoHV-1.2b strain occurred
in a 147 cow dairy herd, being characterised by both
genital and conjunctival signs. The infection was believed
to have been introduced by a hired bull and presenting
signs in the first cows affected included anorexia, milk
drop, bilateral discharge with conjunctival inflammation
and a vaginal discharge 3–5 days after service. These signs
were accompanied by swelling of the vulva and excessive
tail swishing. Cows were pyrexic with a mucopurulent va-
ginal discharge lasting 5–8 days and the vaginal mucosa
was inflamed with numerous focal areas of ulceration,
some of which coalesced, leading to the sloughing of a
yellow- brown necrotic exudate. Respiratory signs such as
coughing and nasal discharge were absent. Over the fol-
lowing 10–14 days 73% of the herd suffered milk drop,
86% had conjunctivitis and 81% had signs of genital infec-
tion. 46% of cows also had hyperaemic teats and discom-
fort milking, with all clinical signs being predominantly
seen in younger cows. In an attempt to control the out-
break a live vaccine was given i.n. one week after the onset
of clinical signs. This led to a rapid recovery of milk yield,
although by this stage a loss of approximately 1000 litres
had been recorded over a six day period. Despite revaccin-
ation 11 months later, 2 cows per week suffered milk drop
during the subsequent milking season with teat discom-
fort again observed. A small number of infected cows had
a mild genital infection characterised by a granular vulvitis
which was considered indicative of a recurrence of latent
infection. Infertility and abortion were not features of the
outbreak. The same study [4] also reports other outbreaks
where milk drop was recorded. In one case a 30% drop
taking 3 months to recover was reported and in another
individual losses were of the order of 15%.
In contrast to the situation in mainland UK the severe
form of respiratory disease due to BoHV-1 was firstdiagnosed in N.I. in the early 1990s (author, personal
observation).
Ireland
Historical information on BoHV-1 in the Republic of
Ireland has been summarized previously [43]. The first
isolate of BoHV-1 was made in 1971 from a case of con-
junctivitis, with eleven more isolates made in the follow-
ing decade, including one from a case of IPV, with no
reports of severe IBR at that time. It was only in the lat-
ter half of the 1980s that the number of reported IBR
outbreaks began to rise, with 102 isolates of BoHV-1 be-
ing made between September 1993 and March 1994.
The first published cases of severe respiratory disease
associated with BoHV-1 in Ireland occurred in the
winter of 1989/1990 in large feedlots in the mid-
Leinster region and were characterised by high mor-
bidity and high mortality, with infection diagnosed by
immunofluorescence, virus isolation and rising anti-
body titres [44].
A later study [43] reported the clinical and molecular
analysis of thirteen BoHV-1 isolates associated with out-
breaks of disease in the Republic of Ireland between
1971 and 1992. Isolates from five outbreaks were identi-
fied as BoHV-1.2 viruses and the remaining eight to
BoHV-1.1, IBR-like strains, the earliest of which was iso-
lated in 1989. Overall, BoHV-1.1 strains were associated
with more severe clinical signs, including systemic infec-
tion of neonatal calves.
Historically the seroprevalence to BoHV-1 in cattle in
both N.I. and the Republic of Ireland was reported to be
low. In the former, a seroprevalence of 13% was found in
cattle older than nine months of age [45], while a 9%
seroprevalence was found in cattle entering feedlots in
the Republic of Ireland during the 1981/1982 season
[44]. More recent studies have consistently reported
markedly increased seroprevalence in both dairy and
beef herds in Ireland. An investigation into the inter-
and intra-herd seroprevalence of BoHV-1 in beef herds
supplying bulls to an Irish performance testing station
found herd prevalence to be 73.2% with a mean within
herd prevalence of 28% (±20%) [46].
A study of 319 dairy herds over the course of their
2009 lactation found approximately 80% to have sero-
logical evidence of exposure to BoHV-1 based on mul-
tiple bulk tank tests with the majority of herds assigned
a high positive score [47]. A serological survey of 1,175
Irish dairy and beef herds in 2009 using serum pools to
estimate herd seroprevalence of 74.9% (95% C.I. 69.9%–
79.8%) [48]. While neither of these studies was able to
differentiate between infected and vaccinated herds, the
finding that less than 2% of herds were vaccinating at
the time supports the conclusion that infection is wide-
spread in Ireland [48].
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in the UK [49], based on a longitudinal survey of 107
unvaccinated dairy and suckler herds in south-west
England between 2002 and 2004. Overall 83.2% (95% C.I.
77.6%–88.8%) were found to contain one or more sero-
positive animal with 42.5% (95% C.I. 41.7%–43.3%) of ani-
mals in these herds always testing positive on serial
sampling.
While no formal study of the association of BoHV-1
with abortion has been carried out in Ireland, surveil-
lance data from the Veterinary Laboratory Service has
found the virus in approximately 3% of foetuses by PCR
(Dr. Ronan O’Neill, personal communication). This is
consistent with results of recent reports from the UK
and USA [50,51].
Wider European and US context
The detection of neutralising antibodies to BoHV-1 in
sera from dairy herds from New York and New Jersey
[41], almost 10 years prior to the recognition in 1954 of
IBR as a disease entity in the USA [4]. This publication
[41] also reports on the isolation of BoHV-1 from cattle
from New York suffering IPV and presented a hypoth-
esis for the emergence of clinical IBR, proposing that
BoHV-1 was maintained in European cattle in the early
1900s primarily as a genital infection (IPV). This was
favoured by the presence of small, relatively isolated
herds with a predominance of natural service in Europe
at that time, with little opportunity for the virus to
undergo extensive serial propagation in the respiratory
tracts of susceptible cattle. It was further proposed that
the virus was introduced to the USA from Europe prior to
1930 when an embargo was imposed on the importation
of cattle from continental Europe. Thereafter the virus ini-
tially became established in the eastern part of the US
where the cattle population was comprised of mainly
small isolated herds with husbandry practices similar to
those in Europe that favoured venereal spread and limited
opportunity for serial respiratory spread. When the virus
gained entry to Western feedlots containing large num-
bers of susceptible animals, there was little opportunity
for virus to be transmitted by the venereal route. However
conditions were ideal for rapid serial passage of virus via
the upper respiratory tract resulting in the selection of a
virus population with a greater predilection for respiratory
rather than reproductive epithelium. Consistent with this
theory is the concurrent emergence of clinical disease in
Californian dairy herds where cattle are maintained in
conditions similar to those of large feedlots and AI rather
than natural service predominated.
Conclusions
IBR as a clinical entity first appeared in feedlots and dair-
ies in the western USA in the 1950s. It is hypothesizedthat this reflected increased opportunity for, and an
adaption to, replication in respiratory mucosa, leading
to the emergence of BoHV-1.1 strains which evolved
from IPV-like strains introduced previously from Europe.
These more virulent IBR-like strains were in turn
transferred to Europe, where severe respiratory disease
emerged from the 1970s onward, becoming evident as
a clinical problem in the UK in the 1970s and on the is-
land of Ireland in the late 1980s/early 1990s. While IBR
dominates the thinking of farmers and veterinary prac-
titioners in relation to the clinical impact of BoHV-1
infection, there is a large body of evidence pointing to-
ward negative reproductive outcomes that should not
be overlooked or dismissed. While interpretation of
some of the work is hindered by a lack of information on
strain types and non-natural routes of infection, a number
of points are evident. Firstly, infection at the time of ser-
vice may reduce fertility, with the potential to cause
chronic necrotising endometritis and oophoritis, accom-
panied by a shortened oestrous cycle. Infection later in the
oestrous cycle may result in a decreased conception rate,
whereas infection later in pregnancy can lead to abortion,
mummification, stillbirth and the birth of live calves which
die shortly thereafter. While negative reproductive out-
comes are to some extent strain-associated (BoHV-1.1),
such distinctions are not absolute. In an Irish context, the
significance of these negative reproductive outcomes is
unknown. Data from elsewhere [52] indicates that, even in
endemically infected dairy herds many heifers are sero-
negative at calving, with the main reservoir of infection
residing in the adult milking herd. Under such conditions
it is not unreasonable to assume that, in the absence of
vaccinal protection, such heifers may be exposed to
BoHV-1 from carrier cows, with the outcome dependent,
at least in part, on the stage of the oestrous cycle or preg-
nancy, the subtype of virus involved and the virulence of
the particular strain. Studies to determine the epidemi-
ology of infection in Irish dairy and suckler herds, and the
prevalence of BoHV-1 subtypes therein are required.
While challenging to conduct, such studies will be neces-
sary to gain a better understanding of the dynamics of in-
fection and the impact of, and losses associated with,
BoHV-1 on reproduction.
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